Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pule

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2023
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAREvangelia Kokalaki, Biao Ma, Mathieu Ferrari, et al.
Science Translational Medicine|January 27, 2017
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cellsWaseem Qasim, Hong Zhan, Sujith Samarasinghe, et al.
Immunity|January 12, 2020
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4<sup>+</sup> T CellsAnna Śledzińska, Maria Vila de Mucha, Katharina Bergerhoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2026
Antibody Format Matters: A Comparative Analysis of VHH and scFv Domains Reveals Superior In Vivo CAR T Cell Function with VHH DomainsAlexander Kinna, Preeta Datta, Reyisa Bughda, et al.
Molecular Therapy. Methods & Clinical Development|January 9, 2023
Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturingLeila Mekkaoui, Jose G Tejerizo, Sara Abreu, et al.
Nature Medicine|November 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trialKate Cwynarski, Gloria Iacoboni, Eleni Tholouli, et al.
Journal for Immunotherapy of Cancer|July 3, 2023
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapyLydia Lee, Wen Chean Lim, Daria Galas-Filipowicz, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
The New England Journal of Medicine|November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2023
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAREvangelia Kokalaki, Biao Ma, Mathieu Ferrari, et al.
Science Translational Medicine|January 27, 2017
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cellsWaseem Qasim, Hong Zhan, Sujith Samarasinghe, et al.
Immunity|January 12, 2020
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4<sup>+</sup> T CellsAnna Śledzińska, Maria Vila de Mucha, Katharina Bergerhoff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2026
Antibody Format Matters: A Comparative Analysis of VHH and scFv Domains Reveals Superior In Vivo CAR T Cell Function with VHH DomainsAlexander Kinna, Preeta Datta, Reyisa Bughda, et al.
Molecular Therapy. Methods & Clinical Development|January 9, 2023
Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturingLeila Mekkaoui, Jose G Tejerizo, Sara Abreu, et al.
Nature Medicine|November 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trialKate Cwynarski, Gloria Iacoboni, Eleni Tholouli, et al.
Journal for Immunotherapy of Cancer|July 3, 2023
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapyLydia Lee, Wen Chean Lim, Daria Galas-Filipowicz, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
The New England Journal of Medicine|November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Pageof 8